MX2009011380A - Utilizacion de dimiracetam en el tratamiento de dolor cronico. - Google Patents

Utilizacion de dimiracetam en el tratamiento de dolor cronico.

Info

Publication number
MX2009011380A
MX2009011380A MX2009011380A MX2009011380A MX2009011380A MX 2009011380 A MX2009011380 A MX 2009011380A MX 2009011380 A MX2009011380 A MX 2009011380A MX 2009011380 A MX2009011380 A MX 2009011380A MX 2009011380 A MX2009011380 A MX 2009011380A
Authority
MX
Mexico
Prior art keywords
dimiracetam
chronic pain
disclosed
treatment
doses
Prior art date
Application number
MX2009011380A
Other languages
English (en)
Spanish (es)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of MX2009011380A publication Critical patent/MX2009011380A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2009011380A 2007-04-16 2008-04-15 Utilizacion de dimiracetam en el tratamiento de dolor cronico. MX2009011380A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000770A ITMI20070770A1 (it) 2007-04-16 2007-04-16 Impiego di dimiracetam nel trattamento del dolore cronico
PCT/EP2008/054553 WO2008125674A1 (en) 2007-04-16 2008-04-15 Use of dimiracetam in the treatment of chronic pain

Publications (1)

Publication Number Publication Date
MX2009011380A true MX2009011380A (es) 2010-07-06

Family

ID=39628738

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011380A MX2009011380A (es) 2007-04-16 2008-04-15 Utilizacion de dimiracetam en el tratamiento de dolor cronico.

Country Status (15)

Country Link
US (2) US7989421B2 (enExample)
EP (3) EP2146706B1 (enExample)
JP (1) JP5409602B2 (enExample)
CN (2) CN103284997B (enExample)
AU (1) AU2008237901B2 (enExample)
BR (1) BRPI0810475A2 (enExample)
CA (1) CA2684363C (enExample)
EA (2) EA019354B1 (enExample)
ES (2) ES2584161T3 (enExample)
IL (2) IL201498A (enExample)
IT (1) ITMI20070770A1 (enExample)
MX (1) MX2009011380A (enExample)
PL (2) PL2857017T3 (enExample)
WO (1) WO2008125674A1 (enExample)
ZA (1) ZA200906991B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
PL2598504T3 (pl) 2010-07-26 2014-10-31 Neurotune Ag Sposób otrzymywania dimiracetamu
EP2658540A1 (en) * 2010-10-29 2013-11-06 Neurotune AG Therapeutic use of dimiracetam to prevent the hand&foot syndrome caused by sorafenib
JPWO2012137645A1 (ja) * 2011-04-07 2014-07-28 旭化成ファーマ株式会社 抗癌剤に起因する異痛症の予防及び／又は治療剤
CN102743372B (zh) * 2012-06-30 2015-09-09 江苏省中医药研究院 一种化疗致血痹动物模型建立方法
JOP20190251A1 (ar) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
MX2020005310A (es) * 2017-11-21 2020-10-08 Medoncare Pharmaceutical Co Ltd Producto de combinacion que comprende dicicloplatino y metodo de preparacion y uso del mismo.
DE102019107619A1 (de) 2019-03-25 2020-10-01 Mondi Ag Verpackungsbeutel aus einem Kunststoffgewebeverbund
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324219A1 (de) * 1983-07-05 1985-01-17 Hoechst Ag, 6230 Frankfurt Mehrlagige elektroisolierfolie
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
IT1233860B (it) 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
GB9123641D0 (en) 1991-11-07 1992-01-02 Isf Spa Process
CA2392879C (en) * 1999-12-01 2005-03-29 Ucb, S.A. A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
CA2684363A1 (en) 2008-10-23
PL2146706T3 (pl) 2015-07-31
US7989421B2 (en) 2011-08-02
PL2857017T3 (pl) 2016-11-30
EP2857017A2 (en) 2015-04-08
IL218851A (en) 2013-09-30
IL201498A (en) 2013-10-31
EA019354B1 (ru) 2014-03-31
EP2857017A3 (en) 2015-05-06
ES2536631T3 (es) 2015-05-27
EP2146706B1 (en) 2015-02-25
IL218851A0 (en) 2012-05-31
US20110251250A1 (en) 2011-10-13
EA022867B1 (ru) 2016-03-31
JP5409602B2 (ja) 2014-02-05
AU2008237901A1 (en) 2008-10-23
ZA200906991B (en) 2011-03-30
ES2584161T3 (es) 2016-09-26
AU2008237901B2 (en) 2013-06-27
CN101677984A (zh) 2010-03-24
EP2620149A2 (en) 2013-07-31
ITMI20070770A1 (it) 2008-10-17
EA200901237A1 (ru) 2010-04-30
EP2146706A1 (en) 2010-01-27
CN103284997B (zh) 2015-06-03
EP2620149A3 (en) 2013-08-07
US8222241B2 (en) 2012-07-17
HK1209053A1 (en) 2016-03-24
WO2008125674A1 (en) 2008-10-23
EA201300826A1 (ru) 2013-11-29
IL201498A0 (en) 2010-05-31
CA2684363C (en) 2016-02-09
BRPI0810475A2 (pt) 2015-10-20
US20100129469A1 (en) 2010-05-27
JP2010524882A (ja) 2010-07-22
CN103284997A (zh) 2013-09-11
EP2857017B1 (en) 2016-05-25

Similar Documents

Publication Publication Date Title
IL218851A (en) Use of dimiracatam for the preparation of a drug for the treatment of chronic pain
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
ZA202006072B (en) Ret inhibitor for use in treating cancer having a ret alteration
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
NZ605841A (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
WO2009005269A3 (en) Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
MX2013013809A (es) Dispositivos expandibles con revestimiento de una composicion de paclitaxel.
RU2018135973A (ru) Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
NZ599265A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
TW200719882A (en) Treatment of connective tissue diseases of the skin
ATE543492T1 (de) Behandlung von lungenkrebs
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
NZ602029A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
PL2244703T3 (pl) Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
WO2012135528A3 (en) Galectin-3c combination therapy for human cancer
EA201390345A1 (ru) Терапевтическое болеутоляющее средство
CR10410A (es) Carboxamidas sustituidas.
DK1971338T3 (da) Kombination af ZD6474 og pemetrexed
MY149863A (en) Delayed-release glucocorticoid treatment of rheumatoid disease
MX2007001206A (es) Metodos para tratar la piel para mejorar el tratamiento terapeutico de la misma.
GEP20063822B (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
MX336477B (es) Derivado de aminoacido.

Legal Events

Date Code Title Description
FG Grant or registration